FindTrial
Sign In

The effects of serous potassium on capsule endoscopy completion rates

The effects of serous potassium on capsule endoscopy completion rates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPN-15007242
Enrollment
Unknown
Registered
2015-10-20
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disease of digestive tract

Interventions

NA:NA

Sponsors

Qingyuan City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: those performed capsule endoscopy during 2015-11-1 to 2017-12-31

Exclusion criteria

Exclusion criteria: patients with a history of gastric and/or small bowel surgery, obstructive symptoms, ileostomies, diabetes mellitus with evidence of end-organ damage, clinical hyper- or hypothyroidism,use of prokinetic medications within 5 days prior to the procedure

Design outcomes

Primary

MeasureTime frame
serous potassium;—

Countries

China

Contacts

Public ContactGan Huoye
gzyghy04@163.com+86 13927688350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026